MD Anderson Cancer Center - News Releasestag:www2.mdanderson.org,2008-09-30:/feeds/newsroom/52016-01-07T14:42:25ZMovable Type Pro 4.25MD Anderson and Kymab announce research and development strategic partnership in immuno-oncologytag:www2.mdanderson.org,2016:/feeds/newsroom//5.36922016-01-07T14:41:56Z2016-01-07T14:42:25ZKymab, a leading human monoclonal antibody biopharmaceutical company, and The University of Texas MD Anderson Oncology Research for Biologics and Immunotherapy Translation (ORBIT) unit today announced a strategic cancer drug discovery and development alliance....
Kymab, a leading human monoclonal antibody biopharmaceutical company, and The University of Texas MD Anderson Oncology Research for Biologics and Immunotherapy Translation (ORBIT) unit today announced a strategic cancer drug discovery and development alliance.
Lymphoma/Myeloma symposium for patients and caregivers set for Feb. 6tag:www2.mdanderson.org,2016:/feeds/newsroom//5.36912016-01-06T16:40:57Z2016-01-07T14:41:46ZPatients with lymphoma or myeloma and their caregivers will have access to leading experts in this field of cancer during an upcoming symposium to be held Feb. 6 in San Antonio....
Patients with lymphoma or myeloma and their caregivers will have access to leading experts in this field of cancer during an upcoming symposium to be held Feb. 6 in San Antonio.
Sugar in Western diets increases risk for breast cancer tumors and metastasistag:www2.mdanderson.org,2015:/feeds/newsroom//5.36902015-12-31T14:39:34Z2016-01-07T14:40:46ZThe high amounts of dietary sugar in the typical Western diet may increase the risk of breast cancer and metastasis to the lungs, according to a study at The University of Texas MD Anderson Cancer Center....
The high amounts of dietary sugar in the typical Western diet may increase the risk of breast cancer and metastasis to the lungs, according to a study at The University of Texas MD Anderson Cancer Center.
Immune suppressor cells identified for advanced prostate cancertag:www2.mdanderson.org,2015:/feeds/newsroom//5.36852015-12-21T18:12:52Z2015-12-21T19:50:51ZImmune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center....
Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.
Pancreas cancer liquid biopsy flows from blood-borne packets of tumor genestag:www2.mdanderson.org,2015:/feeds/newsroom//5.36812015-12-17T16:00:44Z2015-12-17T22:01:59ZPancreatic cancer tumors spill their molecular secrets into the blood stream, shedding their complete DNA and RNA wrapped inside protective lipid particles that make them ripe for analysis with a liquid biopsy, researchers at The University of Texas MD Anderson...
Pancreatic cancer tumors spill their molecular secrets into the blood stream, shedding their complete DNA and RNA wrapped inside protective lipid particles that make them ripe for analysis with a liquid biopsy, researchers at The University of Texas MD Anderson Cancer Center report online at the Annals of Oncology.
Delaying chemotherapy in breast cancer patients reduces overall survival, especially for those with triple-negative breast cancertag:www2.mdanderson.org,2015:/feeds/newsroom//5.36762015-12-10T16:04:09Z2015-12-10T16:46:12ZPostponing the start of adjuvant chemotherapy for more than 90 days following surgery may significantly increase risk of death for breast cancer patients, particularly those with triple-negative breast cancer (TNBC), according to a new study from The University of Texas...
Postponing the start of adjuvant chemotherapy for more than 90 days following surgery may significantly increase risk of death for breast cancer patients, particularly those with triple-negative breast cancer (TNBC), according to a new study from The University of Texas MD Anderson Cancer Center.
Mastectomy plus reconstruction has highest rate of complication, complication-related costs of guideline-concordant therapies for early breast cancertag:www2.mdanderson.org,2015:/feeds/newsroom//5.36752015-12-10T14:03:05Z2015-12-10T16:03:59Zn a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age....
n a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
Multiple myeloma patient study shows promise for natural killer cellstag:www2.mdanderson.org,2015:/feeds/newsroom//5.36732015-12-08T14:35:04Z2015-12-08T14:35:49ZA first-in-human Phase I study of multiple myeloma patients combined expanded cord blood-derived natural killer cells with transplantation of a patient's own stem cells and high-dose chemotherapy with little or none of the side effects seen with current treatments....
A first-in-human Phase I study of multiple myeloma patients combined expanded cord blood-derived natural killer cells with transplantation of a patient's own stem cells and high-dose chemotherapy with little or none of the side effects seen with current treatments.
Loss of enzyme promotes tumor progression in endometrial cancertag:www2.mdanderson.org,2015:/feeds/newsroom//5.36722015-12-07T21:47:13Z2015-12-07T21:47:50ZScientists have shown for the first time why loss of the enzyme CD73 in human cancer promotes tumor progression....
Scientists have shown for the first time why loss of the enzyme CD73 in human cancer promotes tumor progression.
Study shows ibrutinib superior to traditional chemotherapy in untreated chronic leukemia patientstag:www2.mdanderson.org,2015:/feeds/newsroom//5.36712015-12-07T16:49:02Z2015-12-07T16:49:53ZA multi-center, international, randomized, Phase III study of older untreated patients with chronic lymphocytic leukemia (CLL) demonstrated that ibrutinib, a kinase inhibitor, is significantly more effective than traditional chemotherapy with chlorambucil....
A multi-center, international, randomized, Phase III study of older untreated patients with chronic lymphocytic leukemia (CLL) demonstrated that ibrutinib, a kinase inhibitor, is significantly more effective than traditional chemotherapy with chlorambucil.
Depressed head and neck cancer patients three-and-one-half times less likely to survive, have higher recurrence risktag:www2.mdanderson.org,2015:/feeds/newsroom//5.36692015-12-03T21:50:36Z2015-12-03T21:52:52ZDepression is a significant predictor of five-year survival and recurrence in head and neck cancer patients, according to a new study from The University of Texas MD Anderson Cancer Center....
Depression is a significant predictor of five-year survival and recurrence in head and neck cancer patients, according to a new study from The University of Texas MD Anderson Cancer Center.
Boehringer Ingelheim and MD Anderson join forces to discover new treatment approaches for pancreatic cancertag:www2.mdanderson.org,2015:/feeds/newsroom//5.36682015-12-02T21:41:15Z2015-12-03T21:41:44ZBoehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced a collaboration focused on developing innovative medicines for pancreatic ductal adenocarcinoma (PDAC)....
Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced a collaboration focused on developing innovative medicines for pancreatic ductal adenocarcinoma (PDAC).
Complete surgical excision is the most effective treatment for breast implant-associated anaplastic large-cell lymphomatag:www2.mdanderson.org,2015:/feeds/newsroom//5.36662015-12-01T18:11:08Z2015-12-01T18:12:24ZThe optimal treatment approach for most women with breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) is complete surgical excision of the implant and surrounding capsule, according to an international study led by researchers at The University of Texas MD Anderson Cancer...
The optimal treatment approach for most women with breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) is complete surgical excision of the implant and surrounding capsule, according to an international study led by researchers at The University of Texas MD Anderson Cancer Center.
Two MD Anderson faculty named as prestigious AAAS Fellowstag:www2.mdanderson.org,2015:/feeds/newsroom//5.36622015-11-23T17:05:29Z2015-11-23T17:28:03ZDistinguished contributions to understanding p53 tumor suppression in stem cells and breakthrough advances in treating breast cancer have earned two scientists at The University of Texas MD Anderson Cancer Center membership in a notable association of scholars....
Distinguished contributions to understanding p53 tumor suppression in stem cells and breakthrough advances in treating breast cancer have earned two scientists at The University of Texas MD Anderson Cancer Center membership in a notable association of scholars.
Tumor-suppressor p53 regulates protein that stifles immune attack on cancertag:www2.mdanderson.org,2015:/feeds/newsroom//5.36592015-11-20T17:52:28Z2015-11-20T20:53:17ZA crucial tumor-thwarting gene protects an immune attack against lung cancer by blocking the key to an off switch on T cells, the customized warriors of the immune system, a team led by researchers at The University of Texas MD...
A crucial tumor-thwarting gene protects an immune attack against lung cancer by blocking the key to an off switch on T cells, the customized warriors of the immune system, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Institute.